Jiangsu Alphamab Biopharmaceuticals Co., Ltd

This study tests a new drug called JSKN016 combined with chemotherapy or immunotherapy for people with HER2-negative breast cancer that cannot be surgically removed or has spread. About 180 adults aged 18-75 will join. The goal is to see if the combination shrinks tumors and is s…

This early-stage study tests a new drug combination (JSKN016 plus other treatments) in 288 adults with advanced non-small cell lung cancer that has spread and cannot be removed by surgery. The main goals are to see how well the treatment shrinks tumors and to check for side effec…